1. Lncrna ANGPTL1-3 and its target microRNA-30a exhibit potency as biomarkers for bortezomib response and prognosis in multiple myeloma patients
   Fangfang Zhou et al, 2022, Hematology CrossRef
2. Solamargine induces autophagy‐mediated apoptosis and enhances bortezomib activity in multiple myeloma
   Qiaoyan Han et al, 2022, Clinical and Experimental Pharmacology and Physiology CrossRef
3. Long non-coding RNAs (lncRNAs) as prognostic and diagnostic biomarkers in multiple myeloma: A systematic review and meta-analysis
   Mahta Mardani et al, 2022, Pathology - Research and Practice CrossRef
4. Multiple myeloma, a quintessential malignant disease of aging: a geroscience perspective on pathogenesis and treatment
   Veronika S. Urban et al, 2023, GeroScience CrossRef
5. Aberrantly expressed long noncoding RNAs as potential prognostic biomarkers in newly diagnosed multiple myeloma: A systemic review and meta‐analysis
   Jiading Qin et al, 2023, Cancer Medicine CrossRef
6. Non-coding RNAs and exosomal ncRNAs in multiple myeloma: An emphasis on molecular pathways
   Mehrdad Hashemi et al, 2023, European Journal of Pharmacology CrossRef
7. The Expression of Serum lncRNA MIR17HG in Patients with Multiple Myeloma and Its Clinical Significance
   Hongfeng Ge et al, 2023, European Journal of Cancer Care CrossRef